Ikarian Capital, LLC

Ikarian Capital, LLC reported 172 holdings worth US$994M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Ikarian Capital, LLC reported 172 holdings worth US$994M as of Sep 30, 2026. Largest: Kodiak Sciences Inc, Abivax SA and Vaxcyte, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
172
Value as reported
US$994M

The filing in full

CompanySharesValue as reported% of portfolio
Kodiak Sciences Inc533KUS$50.5M5.1%
Abivax SA286KUS$28.4M2.9%
Vaxcyte, Inc.400KUS$22.8M2.3%
Arcus Biosciences, Inc.735KUS$19M1.9%
Celldex Therapeutics, Inc.519KUS$16.8M1.7%
Amylyx Pharmaceuticals, Inc.561KUS$16.3M1.6%
Vera Therapeutics, Inc.400KUS$12.9M1.3%
Alto Neuroscience, Inc.482KUS$12.3M1.2%
Cogent Biosciences, Inc.370KUS$11.9M1.2%
ANI Pharmaceuticals, Inc.149KUS$10.8M1.1%
Enliven Therapeutics, Inc.232KUS$10.6M1.1%
Maze Therapeutics, Inc.301KUS$8.19M0.82%
Contineum Therapeutics, Inc.595KUS$7.98M0.80%
Cue Biopharma, Inc.291KUS$7.52M0.76%
Eupraxia Pharmaceuticals, Inc.810KUS$7.37M0.74%
Tectonic Therapeutic, Inc.306KUS$7.13M0.72%
ORIC Pharmaceuticals, Inc.523KUS$7.04M0.71%
Monopar Therapeutics Inc.86,761US$6.91M0.70%
C4 Therapeutics, Inc.1.93MUS$6.44M0.65%
Alpha Cognition Inc.701KUS$6.31M0.63%
Immunome, Inc.285KUS$6.13M0.62%
Jade Biosciences, Inc.427KUS$6M0.60%
Cybin, Inc.488KUS$5.99M0.60%
Sensei Biotherapeutics, Inc.200KUS$5.94M0.60%
Freenome, Inc.363KUS$5.71M0.57%
Cardiol Therapeutics Inc. Class A3.33MUS$5.52M0.56%
Relmada Therapeutics, Inc.1.45MUS$5.46M0.55%
Pelthos Therapeutics Inc.257KUS$5.39M0.54%
Ovid Therapeutics Inc.2.12MUS$5.28M0.53%
Spruce Biosciences, Inc.101KUS$4.92M0.50%
Vor Biopharma Inc.250KUS$4.77M0.48%
Vogenx Inc209KUS$4.76M0.48%
Viridian Therapeutics, Inc.225KUS$4.63M0.47%
Bright Minds Biosciences Inc.88,951US$4.43M0.45%
Zura Bio Limited1.02MUS$4.24M0.43%
Inventiva SA1.13MUS$4.22M0.42%
Cumberland Pharmaceuticals Inc.503KUS$3.94M0.40%
Septerna, Inc.100KUS$3.91M0.39%
Rezolute, Inc.935KUS$3.87M0.39%
Amanat Acquisition Corp350KUS$3.73M0.37%
CAMP4 Therapeutics Corporation913KUS$3.69M0.37%
Ocugen, Inc.3.56MUS$3.67M0.37%
Alector, Inc.1.98MUS$3.67M0.37%
Olema Pharmaceuticals, Inc.383KUS$3.31M0.33%
Silence Therapeutics PLC822KUS$3.29M0.33%
Ginkgo Bioworks Holdings, Inc.250KUS$3.21M0.32%
Q32 Bio Inc.345KUS$2.85M0.29%
Arvinas, Inc.358KUS$2.77M0.28%
Connect Biopharma Holdings Limited2.24MUS$2.46M0.25%
Rein Therapeutics, Inc.2.95MUS$2.37M0.24%
Kazia Therapeutics Ltd246KUS$2.36M0.24%
Acumen Pharmaceuticals, Inc.1.05MUS$2.34M0.24%
Invivyd, Inc.2.66MUS$2.31M0.23%
ACADIA Pharmaceuticals Inc.112KUS$2.26M0.23%
ProMIS Neurosciences Inc.205KUS$2.22M0.22%
Crescent Biopharma, Inc.150KUS$2.19M0.22%
Obsidian Therapeutics, Inc.159KUS$2.18M0.22%
Capricor Therapeutics, Inc.229KUS$2.17M0.22%
Delcath Systems, Inc.136KUS$2.17M0.22%
4D Molecular Therapeutics, Inc.150KUS$2.15M0.22%
Praxis Precision Medicines, Inc.6,942US$2.02M0.20%
Neuronetics, Inc.810KUS$1.9M0.19%
Biohaven Ltd.133KUS$1.78M0.18%
Lexeo Therapeutics, Inc.513KUS$1.73M0.17%
Verastem, Inc.214KUS$1.72M0.17%
Journey Medical Corporation251KUS$1.72M0.17%
Immunic, Inc.182KUS$1.7M0.17%
PepGen Inc.694KUS$1.68M0.17%
Fulcrum Therapeutics, Inc.449KUS$1.66M0.17%
Tyra Biosciences, Inc.65,000US$1.42M0.14%
Avalo Therapeutics, Inc.90,183US$1.38M0.14%
Cabaletta Bio, Inc.700KUS$1.34M0.14%
Tarsus Pharmaceuticals, Inc.16,858US$1.33M0.13%
Palatin Technologies, Inc.130KUS$1.15M0.12%
iBio, Inc.957KUS$1.13M0.11%
Lipocine Inc.509KUS$1.12M0.11%
Pliant Therapeutics, Inc.1MUS$1.08M0.11%
DBV Technologies SA453KUS$1.07M0.11%
Harrow, Inc.33,275US$1.02M0.10%
Quoin Pharmaceuticals. Ltd212KUS$965K0.10%
Jasper Therapeutics, Inc.1.34MUS$779K0.08%
Neumora Therapeutics, Inc.1.28MUS$762K0.08%
CNS Pharmaceuticals, Inc.136KUS$720K0.07%
Kalaris Therapeutics, Inc.248KUS$717K0.07%
EyePoint, Inc.205KUS$671K0.07%
AEON Biopharma, Inc.2.2MUS$661K0.07%
TCGX Acquisition Corp.50,000US$626K0.06%
Fractyl Health, Inc.1.1MUS$599K0.06%
Foghorn Therapeutics Inc.160KUS$571K0.06%
Adlai Nortye Group Ltd.33,899US$542K0.05%
Palisade Bio, Inc.400KUS$540K0.05%
Equillium, Inc.304KUS$493K0.05%
Sionna Therapeutics, Inc.85,300US$449K0.05%
Lyell Immunopharma, Inc.41,081US$402K0.04%
Anteris Technologies Global Corp.50,862US$395K0.04%
Hyperliquid Strategies Inc30,001US$368K0.04%
Viking Therapeutics, Inc.9,717US$317K0.03%
Solid Biosciences Inc.42,956US$311K0.03%
Lexicon Pharmaceuticals, Inc.165KUS$309K0.03%
Alumis Inc.41,177US$304K0.03%

Every holding of Ikarian Capital, LLC

Source

Download original · View original at SEC

Related